This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Global > United States > Insights > Browse by Content Type > Deloitte Debates > Supply Chain

Global site selector

Supply Chain

Deloitte Debates

This series examines today’s most pressing business issues from many angles. The Debates offer a healthy discussion of options, immediate impacts and long-term consequences. The following Debates address some of your supply chain-related concerns.

Featured Insights

Meet or Exceed: What’s the Best Way to Approach Dodd-Frank’s Data Requirements?
There is no question that financial institutions will face a broad range of new data requirements as a result of the Dodd-Frank law. One question is what to do about it.
Does Sustainability Add Value to M&A Deals?
Increased regulation, stakeholder activism and changing consumer behaviors have made companies realize that sustainability is more than just a public relations issue. But when it comes to M&A, is sustainability really a critical deal issue?
Alternatives to Paying Big Bonuses?
Talent strategies are designed to attract, motivate, and retain employees. In the current economy, what compensation and talent strategies are the most effective for financial services companies?
PMO vs. RMO: Which is the Best Way to Get More Business Value from Your IT Investments?
Program Management Offices (PMOs) are traditionally responsible for improvements in management of IT programs. However, as more value is needed from IT, is the PMO able to shoulder the burden of complex projects, or is something more needed?
Lead or Follow - Should Life Sciences Companies Invest in Electronic Health Records or Wait?
For life sciences companies, is it better to start investing now to help develop EHR standards and capitalize on the potential benefits? Or wait and then follow the crowd?
Managing Risk in the M&A Box
M&A can be risky. Therefore, it’s important to make informed decisions about managing risk. Some companies choose an integrated approach; others limit the responsibility to a specialized deal group. Which approach works better?
The Public Plan Option on Health Care: Holy Grail or Pandora’s Box?
What role should a government sponsored health plan play in achieving health reform goals, and would it result in fewer choices or suboptimal care? Learn about both sides of the Debate.
The Supplier Risk Link: Fix It Fast If It Breaks – or Do Planned Maintenance?
Products or Services: Should Product Manufacturers Increase Their Investment in Services?
Having trouble finding the right balance between products and services? Take a look at the major issues companies are wrestling with and some practical thoughts on ways to tackle the problem.
Corporate Transformation: Under Foot or Under Control?
Traditionally, organizational transformations are closely watched to prevent them from boiling over. Another approach is to run them like a start-up. So, do you keep the transformation close? Or give it some breathing room?